Parkman Healthcare Partners acquired 250,000 Qiagen shares in Q4, comprising 1.5% of its portfolio.

Parkman Healthcare Partners LLC acquired 250,000 shares of Qiagen (NYSE:QGEN) in the 4th quarter, valued at approximately $10.86M, making up 1.5% of the fund's portfolio. Qiagen is now the 20th largest holding for Parkman Healthcare Partners. Other institutional investors like Lindbrook Capital LLC, Xponance Inc., and Tower Research Capital LLC also increased their holdings in Qiagen during the same period.

June 14, 2024
3 Articles